These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10439315)

  • 1. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
    Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
    Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a putative HLA-A*31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma.
    Feenstra M; Bakema J; Verdaasdonk M; Rozemuller E; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Genes Chromosomes Cancer; 2000 Jan; 27(1):26-34. PubMed ID: 10564583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites.
    Mattijssen V; De Mulder PH; Schalkwijk L; Manni JJ; Van 't Hof-Grootenboer B; Ruiter DJ
    Int J Cancer Suppl; 1991; 6():95-100. PubMed ID: 2066187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
    Cabrera T; Concha A; Ruiz-Cabello F; Garrido F
    Scand J Immunol; 1991 Aug; 34(2):147-52. PubMed ID: 1866599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
    Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
    Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing.
    Solheim JC; Harris MR; Kindle CS; Hansen TH
    J Immunol; 1997 Mar; 158(5):2236-41. PubMed ID: 9036970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
    Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
    Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
    Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
    Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
    de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
    J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
    Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
    Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
    Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
    Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.